News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on EMvision Medical Devices.
RELATED STOCKHEAD STORIES
Health & Biotech
Who’s carrying on the Cochlear legacy? The ASX med device stocks that could soar from tailwinds
Health & Biotech
ASX Health Stocks: Cannabis biotech Emyria all set for Phase 1 clinical trial of lead CBD drug
Health & Biotech
ASX Health Stocks: Aussie biotechs Argenica and Antisense take major steps in the US
News
Closing Bell: Lithium debut goes up, health stock debut gets smashed
Tech
Q+A: EMVision on its groundbreaking brain scanner, which could be available in hospitals by 2023
News
Closing Bell: ASX drops again, hit by APRA lending restrictions and NZ rate hike
Health & Biotech
Market Highlights and 5 ASX Small Caps to watch on Wednesday
Health & Biotech
ASX Health Stocks: M&A winds blow as API gets an upgraded offer from Wesfarmers, jumps 15pc
Health & Biotech
ScoPo’s Powerplays: ‘Lots of money on sidelines waiting for pullbacks’, as all eyes are on earnings next week
News
ASX Small Cap Lunch Wrap: Who’s issuing a ‘code red’ today?
Health & Biotech
ASX health stocks: EMV’s brain scanner is completed and ready for testing, stock price jumps 16pc
Health & Biotech
ASX health stocks: AusCann (ASX:AC8) up 5pc after asking for approval of cannabis-based canine drug
News
Market Highlights and 5 ASX Small Caps to watch on Tuesday
Health & Biotech
Why Advanced Human and other ASX imaging stocks have more than doubled in 12 months
Health & Biotech
As health tech soars, these two ASX medical device plays might have flown under the radar
Health & Biotech
Another 2 ASX health stocks confirm they’ve received a major government grant
News
